Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-05

MLTX vs ORIC: stock comparison and AI forecast

Moonlake Immunotherapeutics (MLTX) and Oric Pharmaceuticals, Inc. (ORIC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

MLTX Moonlake Immunotherapeutics

Market Cap
$984M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

ORIC Oric Pharmaceuticals, Inc.

Market Cap
$994M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

MLTX · ORIC

Key facts

  • MLTX and ORIC have similar market capitalizations ($984M and $994M).
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricMLTXORIC
Market Cap$984M$994M
P/B Ratio–2.61x
EPS$-3.33$-1.38
Book Value/Share–$3.68
FCF/Share$-2.87$-1.08

Profitability & Margins

MetricMLTXORIC
ROE–-36.8%
ROA–-34.7%
ROIC–-40.7%
Tax Rate-0.6%–

Financial Health

MetricMLTXORIC
Current Ratio9.13x13.19x
D/E Ratio–0.06x
Financial Leverage–1.06x
Interest Coverage-37.0x–
Working Capital$475M$253M

Cash Flow

MetricMLTXORIC
Operating Cash Flow-$244M-$112M
Free Cash Flow-$244M-$112M
Capital Spending$0.00M-$620K

Income Statement

MetricMLTXORIC
Operating Income-$277M-$156M
Net Income–-$140M
R&D Expense$230M$122M

Dividend & Shareholder Information

MetricMLTXORIC
Shares Outstanding85M104M
FAQ

MLTX vs ORIC: stock comparison and AI forecast

Which is bigger, MLTX or ORIC?

MLTX and ORIC have similar market capitalizations ($984M and $994M).

Which one does Intratio's AI model rank higher, MLTX or ORIC?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.